432 related articles for article (PubMed ID: 26108288)
1. Evaluation of the Immunogenicity of Mycobacterium bovis BCG Delivered by Aerosol to the Lungs of Macaques.
White AD; Sarfas C; West K; Sibley LS; Wareham AS; Clark S; Dennis MJ; Williams A; Marsh PD; Sharpe SA
Clin Vaccine Immunol; 2015 Sep; 22(9):992-1003. PubMed ID: 26108288
[TBL] [Abstract][Full Text] [Related]
2. Alternative BCG delivery strategies improve protection against Mycobacterium tuberculosis in non-human primates: Protection associated with mycobacterial antigen-specific CD4 effector memory T-cell populations.
Sharpe S; White A; Sarfas C; Sibley L; Gleeson F; McIntyre A; Basaraba R; Clark S; Hall G; Rayner E; Williams A; Marsh PD; Dennis M
Tuberculosis (Edinb); 2016 Dec; 101():174-190. PubMed ID: 27865390
[TBL] [Abstract][Full Text] [Related]
3. Polyfunctional CD4 T-cells correlate with in vitro mycobacterial growth inhibition following Mycobacterium bovis BCG-vaccination of infants.
Smith SG; Zelmer A; Blitz R; Fletcher HA; Dockrell HM
Vaccine; 2016 Oct; 34(44):5298-5305. PubMed ID: 27622301
[TBL] [Abstract][Full Text] [Related]
4. Aerosol vaccination with AERAS-402 elicits robust cellular immune responses in the lungs of rhesus macaques but fails to protect against high-dose Mycobacterium tuberculosis challenge.
Darrah PA; Bolton DL; Lackner AA; Kaushal D; Aye PP; Mehra S; Blanchard JL; Didier PJ; Roy CJ; Rao SS; Hokey DA; Scanga CA; Sizemore DR; Sadoff JC; Roederer M; Seder RA
J Immunol; 2014 Aug; 193(4):1799-811. PubMed ID: 25024382
[TBL] [Abstract][Full Text] [Related]
5. Mycobacterium bovis BCG Vaccination Induces Divergent Proinflammatory or Regulatory T Cell Responses in Adults.
Boer MC; Prins C; van Meijgaarden KE; van Dissel JT; Ottenhoff TH; Joosten SA
Clin Vaccine Immunol; 2015 Jul; 22(7):778-88. PubMed ID: 25947145
[TBL] [Abstract][Full Text] [Related]
6. The α4β1 integrin in localization of Mycobacterium tuberculosis-specific T helper type 1 cells to the human lung.
Walrath JR; Silver RF
Am J Respir Cell Mol Biol; 2011 Jul; 45(1):24-30. PubMed ID: 20724551
[TBL] [Abstract][Full Text] [Related]
7. Prime-boost vaccination strategy with bacillus Calmette-Guérin (BCG) and liposomized alpha-crystalline protein 1 reinvigorates BCG potency.
Siddiqui KF; Amir M; Khan N; Rama Krishna G; Sheikh JA; Rajagopal K; Agrewala JN
Clin Exp Immunol; 2015 Aug; 181(2):286-96. PubMed ID: 25845290
[TBL] [Abstract][Full Text] [Related]
8. The immune responses of central and effector memory BCG-specific CD4+ T cells in BCG-vaccinated PPD+ donors were modulated by Treg cells.
Li L; Qiao D; Zhang X; Liu Z; Wu C
Immunobiology; 2011 Apr; 216(4):477-84. PubMed ID: 20950889
[TBL] [Abstract][Full Text] [Related]
9. Dendritic cells induce CD4+ and CD8+ T-cell responses to Mycobacterium bovis and M. avium antigens in Bacille Calmette Guérin vaccinated and nonvaccinated cattle.
Hope JC; Kwong LS; Sopp P; Collins RA; Howard CJ
Scand J Immunol; 2000 Sep; 52(3):285-91. PubMed ID: 10972905
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the safety and immunogenicity of a candidate tuberculosis vaccine, MVA85A, delivered by aerosol to the lungs of macaques.
White AD; Sibley L; Dennis MJ; Gooch K; Betts G; Edwards N; Reyes-Sandoval A; Carroll MW; Williams A; Marsh PD; McShane H; Sharpe SA
Clin Vaccine Immunol; 2013 May; 20(5):663-72. PubMed ID: 23446219
[TBL] [Abstract][Full Text] [Related]
11. Mycobacterium bovis BCG vaccination modulates TNF-alpha production after pulmonary challenge with virulent Mycobacterium tuberculosis in guinea pigs.
Yamamoto T; Lasco TM; Uchida K; Goto Y; Jeevan A; McFarland C; Ly L; Yamamoto S; McMurray DN
Tuberculosis (Edinb); 2007 Mar; 87(2):155-65. PubMed ID: 17289434
[TBL] [Abstract][Full Text] [Related]
12. Photochemically-Mediated Inflammation and Cross-Presentation of
Waeckerle-Men Y; Kotkowska ZK; Bono G; Duda A; Kolm I; Varypataki EM; Amstutz B; Meuli M; Høgset A; Kündig TM; Halin C; Sander P; Johansen P
Front Immunol; 2022; 13():815609. PubMed ID: 35173729
[TBL] [Abstract][Full Text] [Related]
13. Protective Efficacy of Inhaled BCG Vaccination Against Ultra-Low Dose Aerosol
White AD; Sarfas C; Sibley LS; Gullick J; Clark S; Rayner E; Gleeson F; Català M; Nogueira I; Cardona PJ; Vilaplana C; Dennis MJ; Williams A; Sharpe SA
Pharmaceutics; 2020 Apr; 12(5):. PubMed ID: 32344890
[TBL] [Abstract][Full Text] [Related]
14. Accelerating the secondary immune response by inactivating CD4(+)CD25(+) T regulatory cells prior to BCG vaccination does not enhance protection against tuberculosis.
Quinn KM; Rich FJ; Goldsack LM; de Lisle GW; Buddle BM; Delahunt B; Kirman JR
Eur J Immunol; 2008 Mar; 38(3):695-705. PubMed ID: 18266274
[TBL] [Abstract][Full Text] [Related]
15. Purified protein derivative-activated type 1 cytokine-producing CD4+ T lymphocytes in the lung: a characteristic feature of active pulmonary and nonpulmonary tuberculosis.
Barry SM; Lipman MC; Bannister B; Johnson MA; Janossy G
J Infect Dis; 2003 Jan; 187(2):243-50. PubMed ID: 12552448
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of antimycobacterial Th1-cell responses by a Mycobacterium bovis BCG prime-protein boost vaccination strategy.
Lu M; Xia ZY; Bao L
Cell Immunol; 2013; 285(1-2):111-7. PubMed ID: 24177251
[TBL] [Abstract][Full Text] [Related]
17. Attrition of T-cell functions and simultaneous upregulation of inhibitory markers correspond with the waning of BCG-induced protection against tuberculosis in mice.
Nandakumar S; Kannanganat S; Posey JE; Amara RR; Sable SB
PLoS One; 2014; 9(11):e113951. PubMed ID: 25419982
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary immune responses during primary mycobacterium bovis- Calmette-Guerin bacillus infection in C57Bl/6 mice.
Fulton SA; Martin TD; Redline RW; Henry Boom W
Am J Respir Cell Mol Biol; 2000 Mar; 22(3):333-43. PubMed ID: 10696070
[TBL] [Abstract][Full Text] [Related]
19. Lymphatic tracing and T cell responses following oral vaccination with live Mycobacterium bovis (BCG).
Dorer DE; Czepluch W; Lambeth MR; Dunn AC; Reitinger C; Aldwell FE; McLellan AD
Cell Microbiol; 2007 Feb; 9(2):544-53. PubMed ID: 17018037
[TBL] [Abstract][Full Text] [Related]
20. Recombinant BCG::Rv2645 elicits enhanced protective immunity compared to BCG in vivo with induced ISGylation-related genes and Th1 and Th17 responses.
Luo W; Qu Z; Zhang L; Xie Y; Luo F; Tan Y; Pan Q; Zhang XL
Vaccine; 2018 May; 36(21):2998-3009. PubMed ID: 29681409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
